Discover an insightful webinar focusing on the latest US Food and Drug Administration (FDA) guidelines on diversity in clinical trials.
In this webinar, the expert speakers will explore how these new standards can be met and discuss actionable strategies for integrating diversity requirements into clinical trials by optimizing study design and increasing participant engagement.
They will also discuss real-world examples of how organizations have successfully achieved diversity goals and improved clinical trial outcomes. The expert speakers will also provide a detailed understanding of the FDA’s new diversity guidance and focus on the latest requirements for diversity action plans and how these regulations impact study design and clinical trial outcomes.
The attendees will get to learn how study inclusivity can be enhanced by helping to identify diverse patient populations, streamlining participant recruitment and ensuring compliance with the FDA’s new diversity standards.
Register for this webinar today to explore the latest FDA guidelines on clinical trial diversity and how compliance with these standards can be achieved.
Speaker
Joshua Hartman, Director, Clinical Study Feasibility & Analytics, TriNetX
As a Director of Clinical Study Feasibility & Analytics at TriNetX, Joshua Hartman is responsible for providing clinical support to clients conducting trials or research. As Data Quality Specialist at Boston Medical Center, he led data analytics for a large-scale Hepatitis C screening program within an urban safety net hospital, collaborating with clinicians and public health teams, including social workers, pharmacists, and physicians.
He analyzed demographic, risk and linkage to care data from a large hospital population to find patterns and trends for treatment goals using R. As a Production Scientist at Integrated Data Technologies, he synthesized DNA and RNA oligonucleotiedes in a production laboratory for clinicians, researchers and pharmaceutical companies.
He earned his Master’s of Public Health in Epidemiology from Boston University and Bachelor of Science in Biology and Psychology from the University of Iowa.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Director of Feasibility/Feasibility Strategists/Feasibility Lead
- Director of Clinical Trial Design
- Director of Diversity, Equity, and Inclusion in Clinical Trials
- Director/Head of Clinical Trial Diversity
- Professionals involved in clinical development/operations
What You Will Learn
Attendees will learn about:
- The latest FDA guidelines on diversity in clinical trials, including the new requirements for diversity action plans and their impact on study design and outcomes
- Actionable strategies for integrating diversity requirements into clinical trials and optimizing study design and increasing participant engagement
- Real-world examples of how organizations have successfully met diversity goals and improved clinical trial outcomes
- How to address specific questions and challenges related to the new diversity guidance and its implementation
Xtalks Partner
TriNetX
TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account